Clinical trial
Randomized, Double-blind, Placebo-controlled Sequential Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SCYX-7158 After Single Oral Ascending Doses in Healthy Male Volunteers
NCT01533961 is registered in ClinicalTrials.gov with Drugs for Neglected Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double-blind, Placebo-controlled Sequential Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SCYX-7158 After Single Oral Ascending Doses in Healthy Male Volunteers
- Lead sponsor
- Drugs for Neglected Diseases
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 29, 2012
- Completion date
- March 31, 2015
- Enrollment
- 136 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.